Related Experiment Videos
Effect of hemodialysis on gallium-67-citrate scanning
Insights
Gallium-67 citrate scans for detecting inflammation in hemodialysis patients are not affected by the dialysis process. The study found no significant loss of gallium during dialysis, ensuring scan quality remains high.
Area of Science:
- Nuclear Medicine
- Nephrology
Background:
- Gallium-67 citrate scanning is a key diagnostic tool for inflammatory conditions.
- Its use in hemodialysis patients raises concerns about potential interference from the dialysis procedure.
Purpose of the Study:
- To investigate whether hemodialysis affects the quality and accuracy of Gallium-67 citrate scans.
- To quantify any potential loss of Gallium-67 during the dialysis process.
Main Methods:
- Nine hemodialysis patients were studied, with eight undergoing hollow-fiber dialysis and one undergoing ultrafiltration.
- Blood and dialysate samples were analyzed during dialysis.
- Whole-body scans were performed 24 hours post-injection.
Main Results:
- Blood sampling showed no significant decrease in gallium concentration due to dialysis.
- While dialysate activity was detected, reliable quantification of gallium loss was not achieved.
- Ultrafiltration removed approximately 0.5% of the injected gallium dose.
- Whole-body scans demonstrated good image quality, with total counts unaffected by dialysis.
Conclusions:
- Hemodialysis does not adversely impact the quality of Gallium-67 citrate scans.
- The timing of gallium injection relative to dialysis also does not affect scan quality.
- Gallium-67 citrate scanning remains a reliable diagnostic method for inflammatory processes in hemodialysis patients.
Abstract:
Gallium-67-citrate scanning is often used in the diagnosis of inflammatory processes in hemodialysis patients. The question arises whether the dialysis process will adversely affect the quality of the gallium scan. To answer this question, nine dialysis patients were studied, eight on hollow-fiber dialysis units and one on ultrafiltration, in an attempt to quantitate the loss of gallium through dialysis. Blood sampling during dialysis failed to demonstrate changes in gallium concentration attributable to removal by dialysis. Sampling of dialysate demonstrated levels of activity significantly greater than background; however, quantitation was not reliable. Ultrafiltration with total collection of extracted fluids yielded 0.5% of injected dose removed from the blood. Whole-body scans at 24 hours postinjection showed good quality and total counts unaltered by dialysis. The time of injection prior to dialysis also showed no effect on the quality of the final image.